Clinical Research Directory
Browse clinical research sites, groups, and studies.
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Sponsor: ADARx Pharmaceuticals, Inc.
Summary
This study will evaluate the efficacy and safety of ADX-324 in participants with Type 1 or Type 2 hereditary angioedema. The study will also evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and health-related quality of life measures.
Official title: STOP-HAE: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of siRNA Targeting of Prekallikrein With ADX-324 in Participants With Hereditary Angioedema
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2025-08-28
Completion Date
2027-12-31
Last Updated
2026-05-18
Healthy Volunteers
No
Interventions
ADX-324
siRNA duplex oligonucleotide
Placebo
saline
Locations (51)
ADARx Clinical Site
Litchfield Park, Arizona, United States
ADARx Clinical Site
Little Rock, Arkansas, United States
ADARx Clinical Site
San Diego, California, United States
ADARx Clinical Site
Walnut Creek, California, United States
ADARx Clinical Site
Orlando, Florida, United States
ADARx Clinical Site
Chevy Chase, Maryland, United States
ADARx Clinical Site
Wheaton, Maryland, United States
ADARx Clinical Site
Detroit, Michigan, United States
ADARx Clinical Site
St Louis, Missouri, United States
ADARx Clinical Site
Las Vegas, Nevada, United States
ADARx Clinical Site
New York, New York, United States
ADARx Clinical Site
Cincinnati, Ohio, United States
ADARx Clinical Site
Columbus, Ohio, United States
ADARx Clinical Site
Toledo, Ohio, United States
ADARx Clinical Site
Hershey, Pennsylvania, United States
ADARx Clinical Site
Capital Federal, Buenos Aires, Argentina
ADARx Clinical Site
Buenos Aires, Buenos Aires F.D., Argentina
ADARx Clinical Site
Adelaide, South Australia, Australia
ADARx Clinical Site
Vienna, Austria
ADARx Clinical Site
Edegem, Antwerpen, Belgium
ADARx Clinical Site
Sofia, Bulgaria
ADARx Clinical Site
Edmonton, Alberta, Canada
ADARx Clinical Site
Ottawa, Ontario, Canada
ADARx Clinical Site
Montreal, Quebec, Canada
ADARx Clinical Site
Beijing, China
ADARx Clinical Site
Harbin, China
ADARx Clinical Site
Zhengzhou, China
ADARx Clinical Site
Split, Croatia
ADARx Clinical Site
Zagreb, Croatia
ADARx Clinical Site
Hradec Králové, Czechia
ADARx Clinical Site
Prague, Czechia
ADARx Clinical Site
Nice, Alpes-Maritimes, France
ADARx Clinical Site
Tours, Indre-et-Loire, France
ADARx Clinical Site
Montpellier, France
ADARx Clinical Site
Paris, France
ADARx Clinical Site
Tübingen, Baden-Wurttemberg, Germany
ADARx Clinical Site
Hong Kong, Hong Kong
ADARx Clinical Site
Budapest, Hungary
ADARx Clinical Site
Ramat Gan, Tel Aviv, Israel
ADARx Clinical Site
Ashkelon, Israel
ADARx Clinical Site
Tel Aviv, Israel
ADARx Clinical Site
Krakow, Poland
ADARx Clinical Site
Lodz, Poland
ADARx Clinical Site
Wroclaw, Poland
ADARx Clinical Site
Barcelona, Spain
ADARx Clinical Site
Madrid, Spain
ADARx Clinical Site
Taichung, Taiwan
ADARx Clinical Site
Cambridge, United Kingdom
ADARx Clinical Site
Cardiff, United Kingdom
ADARx Clinical Site
London, United Kingdom
ADARx Clinical Site
Southampton, United Kingdom